HOLX vs. PHG, QGEN, CUTR, GEHC, COO, ALNY, WAT, LH, AVTR, and BMRN
Should you be buying Hologic stock or one of its competitors? The main competitors of Hologic include Koninklijke Philips (PHG), Qiagen (QGEN), Cutera (CUTR), GE HealthCare Technologies (GEHC), Cooper Companies (COO), Alnylam Pharmaceuticals (ALNY), Waters (WAT), Laboratory Co. of America (LH), Avantor (AVTR), and BioMarin Pharmaceutical (BMRN).
Koninklijke Philips (NYSE:PHG) and Hologic (NASDAQ:HOLX) are both large-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, profitability, community ranking, institutional ownership, dividends and earnings.
Hologic has a net margin of 12.98% compared to Hologic's net margin of -2.53%. Koninklijke Philips' return on equity of 18.91% beat Hologic's return on equity.
Hologic has lower revenue, but higher earnings than Koninklijke Philips. Koninklijke Philips is trading at a lower price-to-earnings ratio than Hologic, indicating that it is currently the more affordable of the two stocks.
Hologic received 480 more outperform votes than Koninklijke Philips when rated by MarketBeat users. Likewise, 69.66% of users gave Hologic an outperform vote while only 56.97% of users gave Koninklijke Philips an outperform vote.
In the previous week, Koninklijke Philips and Koninklijke Philips both had 8 articles in the media. Koninklijke Philips' average media sentiment score of 1.04 beat Hologic's score of 0.17 indicating that Hologic is being referred to more favorably in the news media.
Koninklijke Philips has a beta of 0.88, indicating that its stock price is 12% less volatile than the S&P 500. Comparatively, Hologic has a beta of 1, indicating that its stock price has a similar volatility profile to the S&P 500.
13.7% of Koninklijke Philips shares are owned by institutional investors. Comparatively, 94.7% of Hologic shares are owned by institutional investors. 1.8% of Hologic shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Hologic has a consensus price target of $87.00, indicating a potential upside of 14.50%. Given Koninklijke Philips' stronger consensus rating and higher probable upside, analysts plainly believe Hologic is more favorable than Koninklijke Philips.
Summary
Hologic beats Koninklijke Philips on 16 of the 17 factors compared between the two stocks.
Get Hologic News Delivered to You Automatically
Sign up to receive the latest news and ratings for HOLX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HOLX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
